Biocryst Pharmaceuticals (BO1.F) Q3 2024 Earnings

Aug 5Confirmed
Q3 2023
Q4 2023
Q2 2024
Q3 2024
-0.29
-0.21
-0.13
-0.05

Details

Expected EPS
-0.15791439999999998
Actual EPS
-0.054768
Surprise EPS
0.1
Surprise Percent
+65.32%

Description

⁨Biocryst Pharmaceuticals⁩ (⁦BO1.F⁩) has reported earnings of ⁦-0.054768⁩ per share for ⁦Q3 2024⁩.

0 Comments

Share your thoughts